Cytosorbents (CTSO) Assets Average (2011 - 2026)
Cytosorbents' (CTSO) quarterly Assets Average came in at $42.4 million in Q1 2026, down 13.66% YoY from $49.1 million in Q1 2025, and down 5.77% on a QoQ basis from $45.0 million in Q4 2025.
Cytosorbents (CTSO) Assets Average (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 15 years of Assets Average data on file, last reported at $42.4 million in Q1 2026.
- Quarterly Assets Average fell 13.66% year-over-year to $42.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.4 million (down 13.66% YoY) and the FY2025 annual result came in at $45.8 million, down 8.75% from the prior year.
- Assets Average retreated to $42.4 million in Q1 2026, from $45.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $86.4 million in Q1 2022 to a low of $42.4 million in Q1 2026.
- A 5-year average of $55.3 million and a median of $50.2 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average slumped 32.01% — and 2024, when it increased 1.21%.
- Tracing CTSO's Assets Average over 5 years: stood at $62.8 million in 2022, then declined by 19.9% to $50.3 million in 2023, then slipped by 5.33% to $47.6 million in 2024, then dropped by 5.51% to $45.0 million in 2025, then declined by 5.77% to $42.4 million in 2026.
- The last three Assets Average figures came in at $42.4 million (Q1 2026), $45.0 million (Q4 2025), and $46.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.11 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 44.78 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.59 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.54 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.19 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.48 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 39.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.26 Mn |
| Mar 31, 2026 | 42.37 Mn |
| Dec 31, 2025 | 44.97 Mn |
| Sep 30, 2025 | 46.87 Mn |
| Jun 30, 2025 | 49.39 Mn |
| Mar 31, 2025 | 49.08 Mn |
| Dec 31, 2024 | 47.59 Mn |
| Sep 30, 2024 | 50.62 Mn |
| Jun 30, 2024 | 50.25 Mn |
| Mar 31, 2024 | 50.01 Mn |
| Dec 31, 2023 | 50.27 Mn |
| Sep 30, 2023 | 50.01 Mn |
| Jun 30, 2023 | 54.95 Mn |
| Mar 31, 2023 | 60.35 Mn |
| Dec 31, 2022 | 62.75 Mn |
| Sep 30, 2022 | 66.74 Mn |
| Jun 30, 2022 | 77.24 Mn |
| Mar 31, 2022 | 86.40 Mn |
| Dec 31, 2021 | 92.29 Mn |
| Sep 30, 2021 | 96.63 Mn |